Literature DB >> 3964798

Ventricular septal defect associated with aneurysm of the membranous septum.

L B Beerman, S C Park, D R Fischer, F J Fricker, R A Mathews, W H Neches, C C Lenox, J R Zuberbuhler.   

Abstract

The most common variety of ventricular septal defect, a perimembranous defect, is frequently associated with a so-called aneurysm of the membranous septum. Previous studies have suggested that ventricular septal defects associated with an aneurysm of the membranous septum tend to spontaneously decrease in size or close more than defects without such an aneurysm. To better define the natural history of this entity, clinical and catheterization data from 87 patients with ventricular septal defect and aneurysm of the membranous septum were reviewed. The initial evaluation was made at a median age of 0.3 years (range 0.1 to 11), with the final evaluation at a median age of 10 years (range 1.5 to 20) and a median duration of follow-up of 8.6 years (range 1.2 to 18.8). Approximately 75% of the ventricular septal defects had a small or no left to right shunt at last evaluation. Overall, 48 patients (55%) had no significant change in the size of the defect, and 39 (45%) showed improvement during the period of observation. Only four patients (5%) had spontaneous closure of the defect. Of the 49 patients who presented with a large left to right shunt, with or without congestive heart failure, 23 (47%) had persistence of a shunt large enough to warrant surgery. When spontaneous improvement occurred, it did so by 6 years of age in all but one patient. Therefore, a continued tendency for a ventricular septal defect associated with an aneurysm of the membranous septum to spontaneously decrease in size or close after this age may be less likely than previously suggested.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1985        PMID: 3964798     DOI: 10.1016/s0735-1097(85)80093-0

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  13 in total

1.  Covert video surveillance: an important investigative tool or a breach of trust?

Authors:  N Shabde; A W Craft
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

2.  Cardiac causes for syncope or sudden death in childhood.

Authors:  C Wren
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

3.  Sudden unexpected non-violent death between 1 and 19 years in north Spain.

Authors:  B Morentin; B Aguilera; P M Garamendi; M P Suarez-Mier
Journal:  Arch Dis Child       Date:  2000-06       Impact factor: 3.791

4.  Unusual hemodynamic changes in an infant with a restrictive ventricular septal defect.

Authors:  Antoine Legendre; Eric Bergoend; Marie Catherine Vaillant; Alain Chantepie
Journal:  Pediatr Cardiol       Date:  2007-09-14       Impact factor: 1.655

5.  Ingestions and overdoses: Changing trends and current controversies.

Authors:  I Dubinsky
Journal:  Can Fam Physician       Date:  1992-08       Impact factor: 3.275

6.  Kinetics of digoxin and anti-digoxin antibody fragments during treatment of digoxin toxicity.

Authors:  A J Sinclair; D S Hewick; P C Johnston; I H Stevenson; M Lemon
Journal:  Br J Clin Pharmacol       Date:  1989-09       Impact factor: 4.335

7.  An association between left axis deviation and an aneurysmal defect in children with a perimembranous ventricular septal defect.

Authors:  O Farrú-Albohaire; G Arcil; I Hernández
Journal:  Br Heart J       Date:  1990-08

Review 8.  A review of spontaneous closure of ventricular septal defect.

Authors:  Jun Zhang; Jong Mi Ko; Joseph M Guileyardo; William C Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-10

9.  Sudden death in children and adolescents.

Authors:  C Wren; J J O'Sullivan; C Wright
Journal:  Heart       Date:  2000-04       Impact factor: 5.994

10.  Aneurysm of the ventricular membranous septum: serial echocardiographic studies.

Authors:  T Miyake; T Shinohara; Y Nakamura; T Fukuda; H Tasato; K Toyohara; Y Tanihira
Journal:  Pediatr Cardiol       Date:  2004 Jul-Aug       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.